Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of UPP1 mRNA | increases expression | 20713471
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of UPP1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of UPP1 mRNA | decreases expression | 18648102
|
C034753 |
5-benzylacyclouridine |
5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine] | decreases reaction|increases activity|increases response to substance | 16397116
|
D000241 |
Adenosine |
UPP1 protein results in increased metabolism of Adenosine | increases metabolic processing | 15772079
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of UPP1 protein | affects expression | 20106945
|
C053541 |
bicalutamide |
bicalutamide results in increased expression of UPP1 mRNA | increases expression | 15638997
|
C006780 |
bisphenol A |
bisphenol A affects the expression of UPP1 mRNA | affects expression | 20170705
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of UPP1 mRNA | decreases expression | 20678512
|
C400082 |
bortezomib |
bortezomib inhibits the reaction [TNF protein results in increased activity of UPP1 protein] | decreases reaction|increases activity | 16397116
|
C400082 |
bortezomib |
bortezomib inhibits the reaction [TNF protein results in increased expression of UPP1 mRNA] | decreases reaction|increases expression | 16397116
|
C400082 |
bortezomib |
bortezomib results in decreased activity of UPP1 protein | decreases activity | 16397116
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of UPP1 mRNA | increases expression | 15336504
|
D002104 |
Cadmium |
Cadmium results in increased expression of UPP1 mRNA | increases expression | 21172416
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of UPP1 mRNA | increases expression | 20106945
|
D003562 |
Cytidine |
UPP1 protein results in increased metabolism of Cytidine | increases metabolic processing | 15772079
|
D004178 |
Diquat |
Diquat results in increased expression of UPP1 mRNA | increases expression | 21172416
|
C025034 |
doxifluridine |
5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine] | decreases reaction|increases activity|increases response to substance | 16397116
|
C025034 |
doxifluridine |
[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine | increases activity|increases response to substance | 16397116
|
C025034 |
doxifluridine |
[TNF protein results in increased expression of UPP1 mRNA] which results in increased susceptibility to doxifluridine | increases expression|increases response to substance | 16397116
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of UPP1 mRNA | decreases expression | 18510171
|
D004958 |
Estradiol |
Estradiol results in increased expression of UPP1 mRNA | increases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of UPP1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of UPP1 mRNA | increases expression | 17557909
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of UPP1 mRNA | increases expression | 15109396
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of UPP1 protein | increases expression | 15331170
|
D005472 |
Fluorouracil |
UPP1 affects the susceptibility to Fluorouracil | affects response to substance | 15067352
|
D005472 |
Fluorouracil |
UPP1 protein affects the susceptibility to Fluorouracil | affects response to substance | 15772079
|
D005472 |
Fluorouracil |
[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil | affects response to substance|increases metabolic processing | 15772079
|
D006151 |
Guanosine |
UPP1 protein results in increased metabolism of Guanosine | increases metabolic processing | 15772079
|
D007213 |
Indomethacin |
Indomethacin results in increased expression of UPP1 mRNA | increases expression | 16984733
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of UPP1 mRNA | increases expression | 20713471
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased expression of UPP1 mRNA | increases expression | 17412507
|
D010424 |
Pentobarbital |
UPP1 protein affects the susceptibility to Pentobarbital | affects response to substance | 15772079
|
D010424 |
Pentobarbital |
[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital | affects response to substance|increases metabolic processing | 15772079
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of UPP1 mRNA | decreases expression | 17426115
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of UPP1 mRNA | increases expression | 18301758
|
C030986 |
pyrimidine |
UPP1 protein results in increased metabolism of pyrimidine | increases metabolic processing | 15772079
|
C009277 |
sodium arsenate |
sodium arsenate results in increased expression of UPP1 mRNA | increases expression | 12727804
|
C025462 |
sulindac sulfide |
sulindac sulfide results in increased expression of UPP1 mRNA | increases expression | 16184548
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of UPP1 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA | increases expression | 16704738
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA | affects cotreatment|increases expression | 17942748
|
D013849 |
Thimerosal |
Thimerosal results in increased expression of UPP1 mRNA | increases expression | 16870260
|
D014529 |
Uridine |
UPP1 protein affects the abundance of Uridine | affects abundance | 15772079
|
D014529 |
Uridine |
UPP1 protein results in increased metabolism of Uridine | increases metabolic processing | 15772079
|
D014529 |
Uridine |
[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil | affects response to substance|increases metabolic processing | 15772079
|
D014529 |
Uridine |
[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital | affects response to substance|increases metabolic processing | 15772079
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of UPP1 mRNA | increases expression | 19101580
|
D002762 |
Cholecalciferol |
Cholecalciferol results in decreased expression of UPP1 mRNA | decreases expression | 16508948
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.23 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.23 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.64 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.61 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.82 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
15.96 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
15.96 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
15.96 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
15.96 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
15.96 | 16537180 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
15.96 | 15688392 15113128 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.22 | 3712494 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
10.22 | 11497255 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
10.22 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.82 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.82 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.23 | 21441931 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
5.04 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
4.40 | 17627676 15579461 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
4.40 | 18759972 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.90 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.75 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.75 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
8.41 | 11141031 18313124 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.41 | 17497229 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.54 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
4.55 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.15 | 11256880 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.84 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.46 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
2.74 | 11248219 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
6.46 | 15687053 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
6.46 | 11922910 |
MESH:D001321 |
Autistic Disorder |
|
Adenosine |
2.75 | 20468076 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.75 | 19232924 17157402 19460635 18775368 15238991 18558336 18985861 18396377 20603192 17507914 18316065 18177632 17688650 16609825 18940202 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
4.71 | 16142846 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.66 | 10684365 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.69 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.91 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.80 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.80 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.46 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.33 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.33 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.37 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.57 | 11985600 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.69 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
4.09 | 12524144 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.53 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
5.48 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
5.48 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
5.48 | 11325840 15692762 16115903 18382427 18234424 15993339 17369602 18695136 17983394 15136595 19526202 16935488 15668708 17426702 15567936 15939500 16322301 16264153 16826403 15994142 15634643 16595493 18628466 16096432 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.48 | 18497071 16675129 17018787 12948864 19861407 17289903 17261762 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
5.48 | 19217205 18357371 16595493 16110121 16557594 15136595 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
5.48 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
5.48 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
5.48 | 11306469 14633655 16253758 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.48 | 20435547 |
MESH:D002056 |
Burns |
|
Indomethacin |
4.39 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.68 | 15141370 16537180 15625704 11239499 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.14 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.25 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
11.25 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
12.51 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
12.51 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
12.51 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
13.18 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.18 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
13.18 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
13.18 | 16023760 16234567 18059187 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.18 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
13.18 | 17971768 17045692 17088986 16799960 18930000 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
13.18 | 16391822 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.66 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
4.40 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
5.02 | 18791128 14736730 11352223 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bortezomib |
5.89 | 16052434 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
5.89 | 12391285 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
14.09 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
14.09 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
14.09 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
14.09 | 17341418 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.08 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.08 | 18986760 17066447 16757204 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
7.08 | 15482327 12636206 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.19 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.32 | 15505089 15476868 18627295 16612575 15792986 17131338 16269455 17519947 16731534 16364871 15811867 17308081 16651473 16952015 16109756 16455267 16278810 17382496 17007740 17924179 17928571 17351982 16242529 17329180 17974986 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.83 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
3.80 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
23.47 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
23.47 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
23.47 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
23.47 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
23.47 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
23.47 | 2727394 7505956 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.59 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.84 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
17.25 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
17.25 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
17.25 | 11677210 17333356 16105132 15861022 17681005 17110522 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
17.25 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.97 | 8697196 12621046 16354765 15668235 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.74 | 17172411 17016597 17287894 16340194 16510598 17169374 15001691 17725105 17018589 18772588 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
3.74 | 15963497 15936596 15625704 11260862 15637740 15786552 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.36 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.36 | 20501625 16331619 18448328 17016601 18802399 18509181 16391804 15148649 16524972 15289873 17695437 18949393 17594712 17255274 17094418 16282729 14970324 17454858 16303861 17401013 18383874 18288408 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
3.36 | 12606626 11197048 18059344 17054584 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.79 | 14669216 17141729 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.39 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
3.66 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.66 | 16575769 17688650 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.70 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.47 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
6.42 | 18759878 11906362 12868966 8156756 11298694 2524372 8970840 14531868 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Thimerosal |
6.42 | 15932584 16958921 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.27 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.19 | 2952479 3621924 |
MESH:D002658 |
Developmental Disabilities |
|
Thimerosal |
4.62 | 15764492 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.59 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.14 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
3.49 | 7237001 7907874 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
17.08 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
17.08 | 8291058 1440618 6482804 7440962 18648102 16192314 9022650 9328219 11289319 6679447 18289764 18692083 9653073 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diquat |
17.08 | 18445702 18164269 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
17.08 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
17.08 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.08 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
17.08 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.32 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.32 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.82 | 18043480 18446180 16133044 17190690 16326151 12774134 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.83 | 11991626 17151854 17351913 11595431 11595415 10671773 16699067 11535926 17329845 17202747 17045617 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.75 | 1851702 |
MESH:D004487 |
Edema |
|
Indomethacin |
9.79 | 19703484 16100529 8985016 8273558 10653021 7990266 7907874 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.79 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.79 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.57 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.88 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
6.83 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.83 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
8.14 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.14 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.83 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
4.18 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.42 | 10567023 16328016 17763956 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.66 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.74 | 11298111 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.84 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.59 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Adenosine |
6.80 | 11404469 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
6.80 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.32 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.98 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.74 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.81 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.81 | 16481741 16337965 15173087 17638652 16785472 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
6.81 | 11005569 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.77 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
16.36 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
16.36 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.36 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
16.36 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.14 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.56 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.82 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Indomethacin |
3.84 | 11852909 17627676 10431976 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.69 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.26 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
18.42 | 10962813 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
18.42 | 14633661 10962813 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
18.42 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
12.95 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
12.95 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.95 | 20067830 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.84 | 11298111 |
MESH:D005756 |
Gastritis |
|
Diquat |
10.74 | 15046732 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
10.74 | 15046732 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.89 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.74 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
6.74 | 12870263 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
9.29 | 16145905 |
MESH:D005910 |
Glioma |
|
Indomethacin |
9.29 | 16487511 18371953 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
9.29 | 9825942 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
4.03 | 11849393 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.78 | 19446573 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.74 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.26 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
5.02 | 11248219 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
11.79 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
11.79 | 15162350 18337622 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
11.79 | 15482327 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.16 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.26 | 16707910 16495754 14766674 16244372 18674790 17875725 17888722 16330681 12587719 18006777 16144979 16879835 16244371 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.38 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.38 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.61 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.09 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.05 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
4.28 | 15633222 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.21 | 6705139 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.37 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.21 | 19772884 19176532 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.21 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.70 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.14 | 18501091 17606976 15147373 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.42 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.54 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 16959395 18606429 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
3.52 | 12727271 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.39 | 17883296 |
MESH:D006934 |
Hypercalcemia |
|
bortezomib |
5.16 | 18089816 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.68 | 12524144 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.90 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
3.86 | 17546600 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.62 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.52 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.52 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.49 | 16569931 16945680 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.69 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
5.02 | 10651667 16133968 10647630 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
5.04 | 16133044 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.16 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Diquat |
10.23 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
10.23 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
10.23 | 7193160 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
4.55 | 7812673 3291741 12568917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.55 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.09 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.09 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.09 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
4.01 | 17329856 15610444 18236018 11686837 11713966 11855677 17994277 15831440 10210152 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
5.04 | 15241188 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.69 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.69 | 10574470 18306037 16133968 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.11 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
17.07 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
17.07 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
17.07 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
17.07 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
17.07 | 17190690 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.86 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
20.55 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
20.55 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
20.55 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
20.55 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
20.55 | 16985049 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.64 | 10320625 12228301 11703811 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.83 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
bortezomib |
4.89 | 18089816 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.69 | 10785260 15631656 16572323 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
bortezomib |
5.99 | 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
5.99 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
5.99 | 16294345 17596541 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
5.04 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.39 | 17980183 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
3.97 | 15526292 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.39 | 11479899 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.99 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Adenosine |
8.16 | 18263696 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.16 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.16 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
8.16 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.16 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.16 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
9.62 | 9163691 18177683 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
9.62 | 17045692 18383874 16603448 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
9.62 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
9.62 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
16.49 | 1399818 6587162 3712494 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
16.49 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
16.49 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
16.49 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.49 | 12151625 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.15 | 16080182 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.93 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
10.01 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
10.01 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
10.01 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
10.01 | 16537180 11053908 11497255 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
10.01 | 1399818 9230183 10545420 20512841 7750092 6695378 15390079 20970405 16337739 11893704 17909032 16271038 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
10.01 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.01 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.47 | 15086387 |
MESH:D008223 |
Lymphoma |
|
bortezomib |
11.53 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
11.53 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
11.53 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
bortezomib |
9.91 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
9.91 | 14633661 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.53 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.25 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
12.64 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
12.64 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.64 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
12.64 | 14999141 16619500 15688392 17131329 16944150 14633655 19196723 17020996 11751437 12931682 10767621 16051031 11807958 10838139 15113128 16827153 15313902 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.15 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
bortezomib |
4.10 | 19213072 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.24 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.93 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.46 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
6.95 | 11903285 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
6.95 | 18803445 18765137 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.21 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.00 | 16757204 18986760 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
8.00 | 12636206 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.46 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
bortezomib |
4.26 | 19112201 19112817 19372569 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.19 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
9.71 | 18186108 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
9.71 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.97 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.24 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.24 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.76 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.43 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.43 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.53 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.81 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.81 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
8.81 | 16537180 11053908 11239499 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
7.42 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
7.42 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.42 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
8.52 | 10663608 15625704 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
8.52 | 12696579 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.41 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.45 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.11 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.39 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.39 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
14.56 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.56 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.56 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.02 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
11.02 | 11749123 18186108 19446573 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.02 | 8888407 16359493 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.16 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.09 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
3.68 | 12349958 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.22 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.73 | 20558911 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.84 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.95 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
7.95 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.69 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.47 | 7009135 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.86 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.66 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.12 | 19401270 |
MESH:D010146 |
Pain |
|
Indomethacin |
3.21 | 17627676 13679232 17440234 3291741 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.35 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.26 | 19003803 16500647 16929163 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
5.26 | 16965848 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.63 | 17883296 15028970 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.39 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.17 | 7296757 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.39 | 16537180 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.84 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.39 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.92 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.82 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.58 | 17225004 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.06 | 15687053 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.14 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.83 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.83 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.25 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.95 | 12371664 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.81 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
14.35 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.35 | 11118676 11222880 11896295 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
14.35 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.58 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.58 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.38 | 18487222 15638997 19240160 19011039 17914592 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.38 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.38 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
2.38 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.38 | 16888761 16729912 18437689 15897917 16868541 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.38 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.38 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.38 | 15682402 12376480 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
3.86 | 11849393 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.99 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.21 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.11 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.46 | 10548101 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.74 | 15538739 16160472 18286688 18722050 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.69 | 10930210 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.90 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.23 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.53 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.31 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
8.31 | 18155124 18172121 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.16 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.87 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.71 | 16767912 17710206 17203757 15625365 15675481 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.93 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.46 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.03 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.72 | 18551238 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
8.72 | 9754883 10087439 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
8.72 | 11738929 1511512 15475178 11044598 17978042 14763951 16876388 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
8.56 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
8.56 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.56 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.25 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.61 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.53 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.21 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
4.09 | 17160473 17207306 10486359 18545984 16280098 10215738 17638125 16113693 10192188 16184426 18209964 15038085 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.40 | 16951190 18567086 19015929 16424979 15786421 17522103 17498489 17172411 18396642 19084572 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
3.40 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
3.40 | 18593901 15930296 16257854 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
3.30 | 17135157 17657623 12500499 18726076 16252198 16631530 11906479 18193104 12498302 17654042 11523592 17895592 11595415 16169175 17627676 17977527 11729361 12787963 11595431 10423059 12077510 16934674 15104355 18181030 15138204 14567935 16397915 12467913 11145282 1323529 18087811 16755016 18209962 18543354 18237397 18299717 10750652 10878458 17918041 18431645 16150113 15255614 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.66 | 16045194 16684133 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
4.70 | 9754883 11529278 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.32 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.88 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
4.91 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.57 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.17 | 1399818 3712494 6587162 7505956 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
15.17 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
15.17 | 18791128 11352223 14736730 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
15.17 | 7505956 3078959 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.35 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.71 | 16280240 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.90 | 17262798 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.57 | 17380554 10574470 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.19 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
7.57 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.57 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
7.57 | 17653716 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.32 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.99 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.60 | 16803524 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.68 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.66 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
8.66 | 18645019 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.65 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.26 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.25 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.90 | 17334414 17638931 17678736 16364871 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.42 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.92 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.11 | 17120751 |